Nasus Pharma H1 EPS $(0.54) Misses $(0.20) Estimate
Nasus Pharma (AMEX:NSRX) reported quarterly losses of $(0.54) per share which missed the analyst consensus estimate of $(0.20) by 170 percent. This is a 217.65 percent decrease over losses of $(0.17) per share from the
Nasus Pharma lost more money per share than experts thought it would, and its losses got much bigger than last year. When a company's losses grow faster than expected, it's a sign to watch whether they're spending too much or if their business is slowing down.
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.